Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Autoimmunity can cause both alopecia areata and idiopathic primary hypophysitis.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Two siblings both had a rare case of alopecia areata at the same time.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Oral baricitinib is effective and safe for treating alopecia areata.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Human Beta Defensin 1 levels do not predict the risk or severity of Alopecia Areata.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

Eosinophilic esophagitis may trigger alopecia areata in some patients.

Alopecia areata patients often have other autoimmune diseases, especially women with nail issues or atopic diseases.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

HLA can be linked to autoimmune hepatitis.

Relapsing polychondritis might be linked to alopecia areata due to immune system factors.

Injecting anti-herpes antibodies locally can prevent skin lesions and sweating problems caused by herpes simplex virus in mice.

Atopic dermatitis patients have much higher acetylcholine levels in their skin, which may cause itching.

Atopy and altered T cell functions contribute to Alopecia Areata.